| ORIGINAL ARTICLE |
|
| Year : 2018 | Volume
: 3
| Issue : 1 | Page : 20-25 |
|
|
Prevalence of metabolic syndrome and its components in nondiabetic Libyan females
Hawa Juma El-Shareif
Department of Endocrine, Tripoli Medical Center, Faculty of Medicine, University of Tripoli, Tripoli, Libya
Correspondence Address:
Prof. Hawa Juma El-Shareif
Department of Endocrine, Tripoli Medical Center, Faculty of Medicine, University of Tripoli, Tripoli
Libya
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/LIUJ.LIUJ_9_18
|
|
|
Background: The metabolic syndrome (MS) is defined as a cluster of cardiovascular risk factors, including central obesity, dysglycemia, hypertension (HPN), elevated triglycerides (TGs), and reduced high-density lipoprotein cholesterol (HDL-C). MS increases the risk of cardiovascular disease and all-cause mortality. Objective: This study aims to estimate the prevalence of MS and its components among nondiabetic Libyan females using the definition proposed by National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III). Methods: A total of 122 randomly selected nondiabetic Libyan females were included in the study. Detailed medical history was obtained from all participants. Blood pressure, weight, height, waist and hip circumference were measured. Body mass index and waist–hip ratio were calculated. Fasting blood glucose (FBG) and lipid profile were collected. Standard oral glucose tolerance test with 75 GM glucose was performed. The MS was defined by ATP III and International Diabetes Federation criteria. Results: According to NCEP definition, the prevalence of the MS in the study group was 42.6%. The most common component was abdominal obesity (67.2%). FBG was ≥ 100 mg/dl in 47.5%. The prevalence of both HPN and low HDL-C was 45.9%. About 26.2% of the participants have their TG ≥ 150 mg/dl; all were MS patients. Conclusions: The prevalence of MS and cardiovascular risk factors were high among Libyan females. Public health authorities and health-care providers should implement strategies for prevention, screening, and management of cardiovascular risk factors to reduce the burden of its potential complications.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
